CRG with CNV loss, such as ATP7B, the expression level was lower in the GBM sample than that in the normal sample, while the other CRG with CNV loss, CDKN2A, was significantly elevated in the GBM sample. This evidence concerns the gene CDKN2A and glioblastoma.